Lv1
38 积分 2024-03-18 加入
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
3小时前
已完结
Genomic spectra of biliary tract cancer
4小时前
已完结
Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation
25天前
已完结
PEG‐Free Monosialoganglioside Lipid Nanoparticles with Spleen‐Selective mRNA Delivery for Cancer Immunotherapy
28天前
已完结
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy
1个月前
已完结
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues
1个月前
已完结
Synthetic Lethality in Cancer Therapeutics: The Next Generation
2个月前
已完结
Synthetic lethality as an engine for cancer drug target discovery
2个月前
已完结
Cholangiocarcinoma — novel biological insights and therapeutic strategies
2个月前
已完结
CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma
2个月前
已完结
皖公网安备34019202002308
